Organ and cell-specifc biomarkers of Long-COVID identifed with targeted proteomics and machine learning

The current lack of Long COVID biomarkers and pathophysiological mechanisms limits effective diagnosis, treatment and disease surveillance. This study, recently published by Molecular Medicine, performed targeted proteomics and machine learning analyses to identify novel blood biomarkers of Long-COVID.

“Optimal protein models, as well as individual proteins, hold the potential for accurate diagnosis of Long COVID and targeted therapeutics”

Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning | Molecular Medicine | Full Text (